Co-existent probable RBD and PD: disease progression, medication response, and  clinical trial Implications

Haotian Zou; Yuanyuan Guo; Christopher Goetz; Tiago Mestre; Glenn Stebbins; Falah Al-Hajraf; Michael A Lawton; Michele T M Hu; Sheng Luo

doi:10.1002/mdc3.13890

Co-existent probable RBD and PD: disease progression, medication response, and clinical trial Implications

Haotian Zou
, Yuanyuan Guo
, Christopher Goetz
, Tiago Mestre
, Glenn Stebbins
, Falah Al-Hajraf
, Michael A Lawton
, Michele T M Hu
, Sheng Luo^*

^*Corresponding author for this work

Bristol Population Health Science Institute

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Citation (Scopus)

Original language	English
Journal	Movement Disorders Clinical Practice
Early online date	21 Nov 2023
DOIs	https://doi.org/10.1002/mdc3.13890
Publication status	E-pub ahead of print - 21 Nov 2023

Bibliographical note

Funding Information:
The work was supported by National Institute on Aging (R01AG064803, P30AG072958, and P30AG028716 to S.L.). The Rush Parkinson's Disease and Movement Disorders Program is a designated Clinical Center of Excellence supported by the Parkinson Foundation. The Oxford Discovery Cohort is funded by Parkinson's United Kingdom (UK) (Project grant J‐2101 “Understanding Parkinson's Progression”) and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. We thank our colleagues, Drs. Claudia Trenkwalder and Cynthia Comella for their helpful suggestions related to this manuscript. Funding Sources and Conflicts of Interest:

Access to Document

10.1002/mdc3.13890

Handle.net

Persistent link

Cite this

@article{4b9e5e508c964c909fccecc75d2131ae,

title = "Co-existent probable RBD and PD: disease progression, medication response, and clinical trial Implications",

author = "Haotian Zou and Yuanyuan Guo and Christopher Goetz and Tiago Mestre and Glenn Stebbins and Falah Al-Hajraf and Lawton, \{Michael A\} and Hu, \{Michele T M\} and Sheng Luo",

note = "Funding Information: The work was supported by National Institute on Aging (R01AG064803, P30AG072958, and P30AG028716 to S.L.). The Rush Parkinson's Disease and Movement Disorders Program is a designated Clinical Center of Excellence supported by the Parkinson Foundation. The Oxford Discovery Cohort is funded by Parkinson's United Kingdom (UK) (Project grant J‐2101 {\textquotedblleft}Understanding Parkinson's Progression{\textquotedblright}) and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. We thank our colleagues, Drs. Claudia Trenkwalder and Cynthia Comella for their helpful suggestions related to this manuscript. Funding Sources and Conflicts of Interest: ",

year = "2023",

month = nov,

day = "21",

doi = "10.1002/mdc3.13890",

language = "English",

journal = "Movement Disorders Clinical Practice",

issn = "2330-1619",

publisher = "John Wiley \& Sons, Ltd.",

}

TY - JOUR

T1 - Co-existent probable RBD and PD: disease progression, medication response, and clinical trial Implications

AU - Zou, Haotian

AU - Guo, Yuanyuan

AU - Goetz, Christopher

AU - Mestre, Tiago

AU - Stebbins, Glenn

AU - Al-Hajraf, Falah

AU - Lawton, Michael A

AU - Hu, Michele T M

AU - Luo, Sheng

N1 - Funding Information: The work was supported by National Institute on Aging (R01AG064803, P30AG072958, and P30AG028716 to S.L.). The Rush Parkinson's Disease and Movement Disorders Program is a designated Clinical Center of Excellence supported by the Parkinson Foundation. The Oxford Discovery Cohort is funded by Parkinson's United Kingdom (UK) (Project grant J‐2101 “Understanding Parkinson's Progression”) and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. We thank our colleagues, Drs. Claudia Trenkwalder and Cynthia Comella for their helpful suggestions related to this manuscript. Funding Sources and Conflicts of Interest:

PY - 2023/11/21

Y1 - 2023/11/21

U2 - 10.1002/mdc3.13890

DO - 10.1002/mdc3.13890

M3 - Article (Academic Journal)

C2 - 38468540

SN - 2330-1619

JO - Movement Disorders Clinical Practice

JF - Movement Disorders Clinical Practice

ER -